A research team has discovered the key role that the APOBEC3A and APOBEC3B enzymes play in driving cancer mutations by modifying the DNA in tumor genomes, offering potential new targets for ...
CRISPR—Clustered Regularly Interspaced Short Palindromic Repeats—is the microbial world’s answer to adaptive immunity. Bacteria don’t generate antibodies when they are invaded by a pathogen and then ...
To many working biologists, DNA-modifying enzymes are tools, not unlike a pair of molecule-sized scissors. To Dr. Barry Stoddard, a professor in the Basic Sciences division at Fred Hutch, these ...
A new base-editing system that uses RNA aptamers to position DNA modifying enzymes at genome targets is adept in performing point-mutation edits and can enhance the therapeutic potential of genome ...
The technology for CRISPR originated in a bacterial immune defense system. Now, the team of one of the researchers who helped pioneer the CRISPR technology, Dr. Feng Zhang, has identified a new type ...
BOULDER, Colo.--(BUSINESS WIRE)--Watchmaker Genomics, a supplier of innovative products for molecular analysis, today announced a multi-year, co-exclusive agreement with Exact Sciences Corporation, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback